Bankrate (NYSE: RATE) 15% LOWER; reported Q1 EPS of $0.19, in-line with the analyst estimate of $0.19. Revenue for the quarter came in at $141.5 million versus the consensus estimate of $137.98 million. Bankrate also announced the results of the internal review conducted by the Audit Committee of the Bankrate Board of Directors and the restatement of its financial statements for fiscal years 2011, 2012 and 2013, the fiscal quarters within those years, and the fiscal quarters ended March 31, 2014 and June 30, 2014.
Organovo (NYSE: ONVO) 8.7% LOWER; announced that it has commenced an underwritten public offering